Keregen

Developing disease modifying drugs for Parkinson's

[RSC ECS 2018 @RSC_ECS]

Innovative chemists - get an abstract in for #ECS2016 and share the stage with @OxbridgeBiotech winner @CambridgeNano and @keregen

[BioMoti @BioMoti]

BioMoti is pleased to announce non-binding Heads of Terms agreement to be acquired by Physiomics Plc (AIM: PYC): https://t.co/k7TZMy7ueL

[RSC ECS 2018 @RSC_ECS]

With @bbcapprentice winner @RickyMartin247 & @OxbridgeBiotech winners @keregen & @camnanocat presenting, #ECS2016 is an entrepreneur feast

[BioIndustry Association (BIA) @BIA_UK]

'Confidence is key' wise words from our panel at #womeninbiotech #IWD2016

[michaeljfox.org @MichaelJFoxOrg]

Did you know? #Parkinsons #PDawareness

[Keregen @keregen]

@DementiaUK #pitchatpalace 5.0 please vote @keregen who are tackling #neurodegeneration in #Parkinsons: https://t.co/AJNZEZndqi

[Keregen @keregen]

@CureParkinsonsT #pitchatpalace biotech comp vote @keregen who are tackling #Parkinsons: https://t.co/AJNZEZndqi

[Keregen @keregen]

#pitchatpalace 5.0 please vote for #keregen who are tackling #parkinsonsdisease #Parkinsons: https://t.co/AJNZEZndqi

[GlobalData Healthcare @Healthcare_GD]

To support @alzheimerssoc’s Dementia Awareness Week, we have created this infographic. #DAW2015